• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

急性心肌梗死后心脏骤停患者预后因素随访研究

Follow-up study of factors influencing prognosis of cardiac arrest patients after acute myocardial infarction

摘要目的 探讨急性心肌梗死(AMI)后心脏骤停(CA)患者恢复自主循环(ROSC)和2年存活的影响因素,ROSC后各因素的生存时间及对2年生存的影响.方法 研究温州医科大附属第一医院2005年1月至2015年1月因AMI致CA并接受心肺复苏(CPR)患者的登记资料,对存活患者随访2年.用单因素Logistic回归分析AMI后CA患者ROSC预后和ROSC患者2年存活预后影响因素,选择有统计学意义的因素分别进行多因素非条件Logistic回归分析.用中位数和四分位数描述ROSC后患者2年期各因素的生存时间,用Kaplan-Meier生存曲线分析因素对2年生存的影响.结果 纳入AMI后CA患者资料254例,其中ROSC 129例,2年存活71例.单因素分析示年龄≥70岁、CA时间22:00-8:00、CPR持续时间≥15 min、肾上腺素用量>5 mg为ROSC预后不利因素;CA前左室射血分数(LVEF)≥40%、CA时有可除颤心律、经皮冠状动脉介入(PCI)治疗为ROSC预后有利因素.年龄≥70岁、CA时气管插管、肾上腺素用量>5 mg、心源性休克为2年存活预后不利因素;男性、CA前活动自如、PCI治疗为2年存活预后有利因素.多因素分析示年龄、CPR持续时间、肾上腺素用量、CA前LVEF、CA时心律、PCI治疗是影响ROSC的独立预测因素,年龄、PCI治疗是影响2年存活的独立预测因素.ROSC后患者各因素相关生存时间中,心包破裂、肾上腺素用量>5 mg、癌症、心源性休克的25%值及中位数值较小,PCI治疗的25%值最大(216 d).Kaplan-Meier生存分析提示年龄≥70岁为2年生存不利因素(Log-rank检验,P=0.007),PCI治疗为2年生存有利因素(Log-rank检验,P<0.01).PCI治疗预后比较分析显示PCI效果与PCI时机、病变血管数目及责任血管情况相关.结论 年龄≥70岁对ROSC、2年存活均为不利因素,PCI治疗对ROSC、2年存活均为有利因素.

更多

abstractsObjective To assess the factors associated with the restoration of spontaneous circulation (ROSC) and 2-year survival prognosis in patients with cardiac arrest (CA) after acute myocardial infarction (AMI),and after ROSC,the effects of various factors on midian survival time and on 2-year survival.Methods In a registry study from January 2005 to January 2015,all consecutive AMI-induced CA patients treated with cardiopulmonary resuscitation (CPR) admitted to our hospital were enrolled.The survivors were followed-up for 2 years.Univariate analysis was applied to evaluate factors associated with rate of ROSC and 2-year survival.Multivariable logistic regression analysis was applied to evaluate statistically significant factors in the univariate analysis.Medians with inter-quartile ranges were used to describe 2-year survival time affected by various factors after ROSC.Kaplan-Meier survival curve analysis was used to evaluate the effect of factors on 2-year survival.Results A total of 254 cases with CA after AMI were enrolled,including 129 cases of ROSC and 71 cases of 2-year survival.Univariate analysis showed age ≥ 70 years,CA occurred during 22:00-8:00,the duration time ofCPR ≥ 15 min and adrenaline dosage > 5 mg were unfavorable predictors of ROSC;while,left ventricular ejection fraction (LVEF) ≥ 40% before CA,shockable rhythm and percutaneous coronary intervention (PCI) therapy were favorable predictors.Besides,age ≥ 70 years,intubation during CPR,adrenaline dosage > 5 mg and cardiogenic shock were unfavorable predictors of 2-year survival;While,male,normal daily activity before CA and PCI treatment were favorable predictors.Multivariable analysis showed age,the duration of CPR,adrenaline dosage,LVEF before CA,the rhythm during CPR and PCI therapy were independent predictors of ROSC.Age and PCI therapy were independent predictors of 2-year survival.Among patients,the survival time was affected by various factors after ROSC,and the factors with minimum 25% and small median value were associated with cardiac rupture,cancer,adrenaline dosage > 5 mg and cardiogenic shock.The factor with maximum 25% value was PCI treatment (216 days).Kaplan-Meier survival analysis suggested that age ≥ 70 years was an unfavorable factor of 2-years survival (Log-rank test,P=0.007);while,PCI treatment was a favorable factor (Log-rank test,P<0.01).PCI-related prognosis analysis showed that the effectiveness of PCI was related to the timing of PCI,the number of infarctrelated artery and the difference in culprit lesion.Conclusions The age ≥ 70 years was disadvantageous to both ROSC and 2-year survival.PCI treatment was favorable to both ROSC and 2-year survival.

More
广告
  • 浏览390
  • 下载264
中华急诊医学杂志

中华急诊医学杂志

2018年27卷7期

740-746页

ISTICPKUCSCDCA

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷